Lipocine Inc. (LPCN) vs Palatin Technologies, Inc. (PTN)
Lipocine Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Lipocine Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.2M). Lipocine Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 86.5% against −63.5%. Palatin Technologies, Inc. has the higher net margin (−47.2% vs −755.1%) and the lower return on invested capital (−942.3% vs 0.00%). Across the 16 metrics below, Palatin Technologies, Inc. leads on 9 and Lipocine Inc. on 7.
Valuation
Profitability
| Metric | LPCN | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (800.80%) | (49.26%) | 0.00% |
| Net margin | (755.11%) | (47.22%) | 0.00% |
| Free cash flow margin | (713.02%) | (113.25%) | 0.00% |
| Return on equity | (60.94%) | (297.25%) | (57.72%) |
| Return on assets | (55.89%) | (73.72%) | (49.22%) |
| Return on invested capital | 0.00% | (942.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack